08 / Industry · Analysis
SumbitAI secures ₩15 billion in investment and R&D support
The combined Series A investment and future research support require a distinction between completed funding, the support ceiling and its payment period.
SumbitAI secured ₩15 billion in investment and research support. ZDNet Korea reported cumulative funding of about ₩20 billion. That total includes an earlier seed investment.
According to ZDNet Korea, the package combines two funding streams. One is a completed investment round; the other is future research support. Their combined value therefore needs to be read alongside the payment terms.
ZDNet Korea reported plans to expand into 3D multi-sequence image reading. This involves interpreting several sets of medical images together. The selected research project also covers global commercialisation.
Investment and research support
ZDNet Korea reported a Series A round of about ₩12 billion. SV Investment led it, with earlier sole seed investor Altos Ventures joining. Kiwoom Investment and iM Investment Partners also participated.
The report also outlined support under the specialised Scale-up TIPS scheme. Run by Korea's Ministry of SMEs and Startups, it provides R&D support. SumbitAI's support is capped at ₩3 billion over the next three years.
Expansion into CT and MRI interpretation
According to ZDNet Korea, the project covers generative AI for CT and MRI. Its scope includes multi-sequence solutions and global commercialisation. That connects the research support to the planned market expansion.
ZDNet Korea reported that SumbitAI raised ₩5 billion from Altos in 2024. The Korean medical imaging AI company now combines follow-on funding with R&D support. The distinction remains between the completed round and support paid over time.